Dec 31, 2019

Perrigo Q4 2019 Earnings Report

Perrigo's Q4 2019 earnings were released, highlighted by record consumer self-care Americas net sales and progress in transforming into a consumer self-care company.

Key Takeaways

Perrigo reported a 10.7% increase in consolidated net sales to $1.3 billion for Q4 2019, driven by increased demand, the addition of Ranir, and new product sales. Adjusted diluted EPS increased 9.3% to $1.06.

Consolidated net sales increased by 10.7% to $1.3 billion.

Consumer Self-Care Americas achieved record fourth quarter reported net sales of $711 million, a 15.2% increase.

Reported diluted loss per share was $0.14, compared to earnings per share of $0.60 in the prior year quarter.

Adjusted diluted EPS increased 9.3% to $1.06.

Total Revenue
$1.32B
Previous year: $1.2B
+10.7%
EPS
$1.06
Previous year: $0.97
+9.3%
Adjusted Operating Income
$214M
Reported Operating Margin
-0.01%
Adjusted Gross Margin
40.1%
Gross Profit
$481M
Previous year: $443M
+8.6%
Cash and Equivalents
$354M
Previous year: $551M
-35.7%
Free Cash Flow
$42.1M
Previous year: $149M
-71.6%
Total Assets
$11.3B
Previous year: $11B
+2.9%

Perrigo

Perrigo

Perrigo Revenue by Segment

Forward Guidance

Perrigo expects fiscal 2020 net sales growth of 6% to 7%, with organic net sales growth of approximately 3%. Adjusted diluted EPS is expected to be between $3.95 to $4.15, which includes $50 million in transformational investments.

Positive Outlook

  • Expects net sales growth of approximately 6% to 7%.
  • Expects organic net sales growth of approximately 3%.
  • Adjusted diluted EPS is expected to be between $3.95 to $4.15.
  • Continuing to make necessary investments in the business.
  • Setting the stage for 5% adjusted operating profit growth in Year 3.

Revenue & Expenses

Visualization of income flow from segment revenue to net income